Red cell pyruvate kinase deficiency: From genetics to clinical manifestations

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 1, 2000, Pages 57-81

  Zanella, Alberto ^a   Bianchi, Paola ^b  

^a Division of Haematology   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Glycolysis; Haemolytic anaemia; PK LR gene; Pyruvate kinase deficiency; Red cell enzymes

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; FOLIC ACID; GLUCOCORTICOID; IRON; PYRUVATE KINASE;

ACCURACY; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUCASIAN; CHEMICAL STRUCTURE; CHILD; CHROMOSOME 1; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ANALYSIS; ENZYME DEFICIENCY; ERYTHROCYTE DISORDER; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; GENE LOCATION; GENE THERAPY; GENETICS; GENOTYPE; HEREDITARY HEMOLYTIC ANEMIA; HOMOZYGOSITY; HUMAN; INFANT; IRON DEFICIENCY; MALE; MISSENSE MUTATION; NEWBORN; NEWBORN ANEMIA; NEWBORN JAUNDICE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; SPLENECTOMY;

EID: 0034431029     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0057     Document Type: Article

References (119)

1. Pyruvate kinase and other enzymopathies of the erythrocyte
2. Pyruvate-kinase (PK) deficiency
3. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia
4. Familial hemolytic anemia resulting from an abnormal red blood cell pyruvate kinase
5. Neonatal hemolysis due to a transient severity of inherited pyruvate kinase deficiency
6. An isozyme of erythrocyte pyruvate kinase (PK Los Angeles) with impaired kinetics corrected by fructose-1,6-diphosphate
7. Chronic haemolytic anaemia in two patients heterozygous for erythrocyte pyruvate kinase deficiency. Electrofocusing and immunological studies of erythrocyte and liver pyruvate kinase
8. The role of potassium in muscle phosphorylation
9. Dual divalent cation requirement for activation of pyruvate kinase: Essential roles of both enzyme- and nucleotide-bound metal ion
10. Pyruvate kinase
11. Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: A review
12. Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies
13. The human liver-type pyruvate kinase (PKL) gene is on chromosome I at band q21
14. The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters
15. 2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma
16. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing
17. Hereditary persistence of fetal erythrocyte pyruvate kinase in the basenji dog
18. The molecular basis of canine pyruvate kinase deficiency
19. Change of pyruvate kinase isozymes from M2- to L-type during development of the red cell
20. Pattern of pyruvate kinase isozymes in erythroleukemia cell lines and normal human erythroblasts
21. Evidence for a postsynthetic proteolytic transformation of erythrocyte pyruvate kinase into L-type enzyme
22. The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver
23. The structure of cat muscle pyruvate kinase
24. Changes in activities and isozyme patterns of glycolytic enzymes during erythroid differentiation in vitro
25. Refined three-dimensional structure of cat-muscle (MI) pyruvate kinase at a resolution of 2.6 A
26. The allosteric regulation of pyruvate kinase
27. Crystal structure of Escherichia coli pyruvate kinase type I: Molecular basis of the allosteric transition
28. The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate
29. Human liver type pyruvate kinase: Complete amino acid sequence and the expression in mammalian cells
30. cDNA cloning of human R-type pyruvate kinase and identification of a single amino acid substitution (Thr384 → Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia
31. Complete genomic sequences of the human PK-L/R-gene includes four intragenic polymorphisms defining different haplotype backgrounds of normal and mutant PK-genes
32. Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells
33. Identification of a novel promoter mutation in the human pyruvate kinase (PK) LR gene of a patient with severe haemolytic anaemia
34. Hematologically important mutations: Red cell pyruvate kinase (2nd update)
35. Molecular characterization of the PK-LR gene in pyruvate kinase deficient Spanish patients
36. PK-LR gene mutations in pyruvate kinase deficient Portuguese patients
37. Original mutations in the LR-PK gene associated with chronic non-spherocytic, hemolytic anemia
38. Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia
39. Novel mutations in the human red cell type pyruvate kinase gene: Two promoter mutations in cis, a splice site mutation, a nonsense- and three missense mutations
40. Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia
41. Mutations in the pyruvate kinase L gene in patients with hereditary hemolytic anemia
42. G → T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP
43. Estimating the prevalence of pyruvate kinase deficiency in the general white population
44. Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients
45. Compound heterozygous mutations affecting both hepatic and erythrocyte isozymes of pyruvate kinase
46. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency
47. Study of the molecular defects in pyruvate kinase deficient patients affected by nonspherocytic hemolytic anemia
48. Five unknown mutations in the LR pyruvate kinase gene associated with severe hereditary nonspherocytic haemolytic anaemia in France
49. A new sickle cell disease phenotype association Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry)
50. Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia
51. Molecular heterogeneity of pyruvate kinase deficiency identified by single strand conformational polymorphism (SSCP) analysis
52. Six previously undescribed pyruvate kinase mutations causing enzyme deficiency
53. Point mutations in theL-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency
54. Molecular analysis of 29 pyruvate kinase-deficient patients from Central Europe with hereditary hemolytic anemia
55. Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency
56. Low substrate affinity of pyruvate kinase variant (PK Sapporo) caused by a single amino acid substitution (426 Arg → Gln) associated with hereditary hemolytic anemia
57. Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong Kong
58. Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish
59. Novel mutations and structural implications in R-type pyruvate kinase-deficient patients from Southern Italy
60. Monoallelic expression of pyruvate kinase (PK) gene in the two PK variants associated with hereditary hemolytic anemia
61. Exonic point mutation 1552 CGT → AGT is not a missense mutation but causes an aberrant splicing of human L-type pyruvate kinase gene
62. A novel mutation in the human red cell type pyruvate kinase gene causing hereditary nonspherocytic hemolytic anemia
63. Identification of a novel mutation (PK-Dordrecht) and a novel polymorphism in the human red cell type pyruvate kinase gene
64. Molecular basis of severe pyruvate kinase deficiency
65. Molecular modelling of human red blood cell pyruvate kinase: Structural implications of a novel G1091 to A mutation causing severe nonspherocytic hemolitic anemia
66. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: A single amino acid substitution near the active site and decreased mRNA content of the R-type PK
67. Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia
68. PK Mondor: Prenatal diagnosis of a frameshift mutation in the LR pyruvate kinase gene associated with severe hereditary non-spherocytic haemolytic anaemia
69. Study of the molecular defects in pyruvate kinase (PK) deficient patients affected by hereditary nonspherocytic hemolytic anemia (HNHA)
70. Cumulative information of genotype-phenotype relationship of the homozygous pyruvate kinase deficiency
71. Trinucleotide repeat polymorphism at the PKLR locus
72. The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: A viewpoint
73. The primary cause of hemolysis in enzymopathies of anaerobic glycolysis. A commentary
74. Disorders of erythrocyte metabolism
75. Pyruvate kinase deficiency
76. Impaired nicotinamide adenine dinucleotide synthesis in pyruvate kinase deficient human erythrocytes. A mechanism for decreased total NADH content and a possible secondary cause of hemolysis
77. Hereditary non spherocytic haemolytic anaemia: A study of red cell carbohydrate metabolism in twelve cases of pyruvate-kinase deficiency
78. Decrease in subunit aggregation of phosphoribosyl pyrophosphate synthetase: A mechanism for decreased nucleotide concentrations in pyruvate kinase deficient human erythrocytes
79. Regulatory properties of human erythrocyte hexokinase during cell ageing
80. Impaired erythrocyte phosphoribosyl pyrophosphate formation in hemolytic anemia due to pyruvate kinase deficiency
81. Inhibition of transketolase and transaldolase of the human hemolysate by multivalent anions
82. Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate
83. Inhibition of the pentose phosphate shunt by 2,3 diphosphoglycerate in erythrocyte pyruvate kinase deficiency
84. Extreme hemolysis and red-cell distortion in erythrocyte pyruvate kinase deficiency. II. Measurements of erythrocyte glucose consumption, potassium flux and adenosine triphosphate stability
85. Normalisation of red cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatment
86. Hereditary pyruvate kinase deficiency: Role of the abnormal enzyme in red cell pathophysiology
87. Increased adsorption of cytoplasmic proteins to the erythrocyte membrane in ATP-depleted normal and pyruvate-kinase-deficient mature cells and reticulocytes
88. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia
89. Membrane abnormalities of pyruvate kinase deficient red cell
90. Hereditary non-spherocytic hemolytic anemia of the pyruvate-kinase deficient type
91. Sequestration and destruction of reticulocytes in the spleen in pyruvate kinase deficiency hereditary non-spherocytic hemolytic anemia
92. Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency
93. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki
94. Liver pyruvate kinase (PK) isozymes in a PK-deficient patient
95. Anémie hémolytique héreditaire par déficit en pyruvate-kinase: Pronostic des formes neonatales
96. Fetal anemia due to pyruvate kinase deficiency
97. Hydrops foetalis associated with red cell pyruvate kinase deficiency
98. Pyruvate kinase deficiency: An unusual cause of puerperal jaundice
99. Exercise with anemia: The role of the left-shifted or right-shifted oxygen-hemoglobin equilibrium curve
100. Erythrocyte enzyme deficiencies: Pyruvate kinase deficiency
101. Iron status in red cell pyruvate kinase deficiency: Study of Italian cases
102. Red cell enzymopathies of the glycolytic pathway
103. Erythrocyte populations in pyruvate kinase deficiency anemia following splenectomy. I. Cell morphology
104. Why has the autohemolysis test not gone the way of the cephalin flocculation test?
105. Diagnostic strategy in a suspected red cell enzymopathy
106. Congenital non-spherocytic haemolytic anaemias
107. Red cell metabolism
108. Red cell 3-phosphoglycerate levels as a diagnostic aid in pyruvate kinase deficiency
109. 2,3-diphosphoglycerate and 3-phosphoglycerate in red cell pyruvate kinase deficiency
110. Recommended methods for the characterization of red cell pyruvate kinase variants
111. Erythrocyte pyruvate kinase deficiency: II new cases
112. Pyruvate kinase deficiency: Historical perspective and recent progress of molecular genetics
113. Prenatal diagnosis of pyruvate kinase deficiency
114. Erythrocyte pyruvate kinase and glucose phosphate isomerase deficiency: Perturbation of glycolysis by structural defects and functional alterations of defective enzymes and its relation to the clinical hemolytic anemia
115. Effects of sulphydryl compounds on abnormal red cell pyruvate kinase
116. + and pyruvate
117. Bone marrow, peripheral blood and cord blood stem cell transplantation in children: Ten years' experience at Siriraj Hospital
118. Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: Implications for gene therapy of human PK deficiency
119. Red cell enzyme deficiencies: From genetic basis to gene transfer